According to the on-site negotiation/auction of the 2024 medical insurance catalog, the second day of the 2024 National Drug Price Negotiation started around 8 o'clock. Shenzhen Salubris Pharmaceuticals, Haisco Pharmaceutical Group, and Jiangsu Hengrui Pharmaceuticals brought their first batch of varieties to the scene, with Jiangsu Hengrui Pharmaceuticals planning negotiations for three diabetes drugs in the morning. The Caixin reporter learned that yesterday, as the first day of the national negotiation, Jiangsu Hengrui Pharmaceuticals, Humanwell Healthcare, Sichuan Kelun Pharmaceutical, and more than 40 other companies battled for over 8 hours, involving categories such as antihypertensive drugs, psychotropic drugs, and orphan drugs. (Caixin reporters He Fan and Lu Afeng)